drugset / Trial / NCT02291991
Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, placebo controlled, single dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of GX-E2 in healthy male subjects.
Timeline
- Start
- 2014-11
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GX-E2 | Unknown | 8 ug/kg | Intravenous |
Indications
No indication recorded.